Cathy Demeestere to Serve as Interim Director General of FECC

Cathy Demeestere, the former secretary general and CEO of EPCA, serves as the...
Cathy Demeestere, the former secretary general and CEO of EPCA, serves as the interim director general of the FECC, pending the appointment of a permanent director general during the course of 2019.

The board of the European Association of Chemical Distributors (FECC) has announced that Cathy Demeestere will serve as the interim director general of the association; effective 16 August 2018, and pending the appointment of a permanent director general during the course of 2019. She temporarily fills the vacant position previously held by Elisa Setién, who left FECC on August 15 after two and a half years to take over a new position in the chemical sector in Brussels.

Cathy Demeestere is the former secretary general and CEO of EPCA, the European Petrochemical Association. She officially retired at the end of 2017. Serving as the interim director general of FECC, she brings her 45 years of global business experience to the association, of which 30 years was on a general management level. Prior to association management she was active through the whole petrochemical value chain from oil and gas, paints to petrochemicals and polymers, as well as chemical logistics. A lawyer by training (Ghent University, Belgium), Cathy benefited from an extensive post-graduate executive education. She is, amongst others, an alumna of Harvard Business School (ISMP 1992) and the MIT Centre for Transportation and Logistics (2011 Strategic Supply Chain Management).

Company

Logo:

FECC - European Association of Chemical Distributors

Rue du Luxembourg 16B
1000 Brussels, Belgium
Belgium

Company contact







Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.